|
Volumn 45, Issue 1-3, 2001, Pages 53-56
|
Proof of efficacy trials: Endpoints
|
Author keywords
Antiepileptic drugs; Endpoints; Proof of efficacy trials; Response ratio; Seizure frequency
|
Indexed keywords
ANTICONVULSIVE AGENT;
LAMOTRIGINE;
ANTICONVULSANT THERAPY;
CHALFONT SCALE;
COMPLEX PARTIAL SEIZURE;
CONFERENCE PAPER;
DISEASE COURSE;
DISEASE SEVERITY;
DRUG EFFICACY;
FOCAL EPILEPSY;
GRAND MAL SEIZURE;
HUMAN;
LIVERPOOL SCALE;
PRIORITY JOURNAL;
RATING SCALE;
SEIZURE;
TREATMENT OUTCOME;
VA COOPERATIVE STUDY SEIZURE SEVERITY SCALE;
ANTICONVULSANTS;
ENDPOINT DETERMINATION;
EPILEPSY;
HUMANS;
RESEARCH DESIGN;
|
EID: 0034913378
PISSN: 09201211
EISSN: None
Source Type: Journal
DOI: 10.1016/S0920-1211(01)00216-9 Document Type: Conference Paper |
Times cited : (25)
|
References (10)
|